Sanofi Pasteur MSD Limited

Mallards Reach, Bridge Avenue, Maidenhead, Berkshire, SL6 1QP
Telephone: +44 (0)1628 785 291
Fax: +44 (0)1628 671 722
Medical Information Direct Line: +44 (0)1628 587 693
Medical Information e-mail: medinfo@spmsd.com
Medical Information Fax: +44 (0)1628 635 072

Summary of Product Characteristics last updated on the eMC: 16/08/2011
SPC Inactivated Influenza Vaccine (Split Virion) BP

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 16/08/2011 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   21-Jul-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

change of the annual year of the strain
Updated on 16/05/2011 and displayed until 16/08/2011
Reasons for adding or updating:
  • Change to section 6. 6 - Instructions for use, handling and disposal
Date of revision of text on the SPC:   01-Apr-2011
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company


New plungestopper
Updated on 10/08/2010 and displayed until 16/05/2011
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   29-Jul-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Change to flu strain

Updated on 29/07/2010 and displayed until 10/08/2010
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   22-Jul-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Annual strain change
Updated on 19/07/2010 and displayed until 29/07/2010
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • Change to section 4.3 - Contraindications
  • Change to section 6. 6 - Instructions for use, handling and disposal
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   01-Apr-2010
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



re-wording of section 4.3

Section 6.6 moving place of a senctence.
Updated on 14/08/2009 and displayed until 19/07/2010
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   06-Aug-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 2- Influenza strains updated
Updated on 23/06/2009 and displayed until 14/08/2009
Reasons for adding or updating:
  • Change to section 6. 5 - Nature and Contents of Container
  • Change to section 6. 6 - Instructions for use, handling and disposal
Date of revision of text on the SPC:   01-Jun-2009
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Flu strains for season 2008/09
Section 6.5: Removal of following: ‘and a tip cap (chlorobromobutyl)’

Section 6.6: Addition of sentence ‘The vaccine should not be used if foreign particles are present in the suspension’
Updated on 29/08/2008 and displayed until 23/06/2009
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
  • SPC Retired pending re-submission
Date of revision of text on the SPC:   01-Aug-2008
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company



Revision due to annual strain change.

Section 2

Strain changes

Season detail changes

Updated on 08/08/2008 and displayed until 29/08/2008
Reasons for adding or updating:
  • Change to section 9 - Date of first Authorisation/renewal of the Authorisation
Date of revision of text on the SPC:   30-Dec-2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 9 (Date of first authorisation/renewal of the authorisation), has been updated to reflect renewal on 30 December 2007
Updated on 17/08/2007 and displayed until 08/08/2008
Reasons for adding or updating:
  • Change to section 2 - Qualitative and quantitative composition
Date of revision of text on the SPC:   08/2007
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 2 - updated to include the strains recommended by the WHO for 2007-2008.
Updated on 18/09/2006 and displayed until 17/08/2007
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 4.8 - Undesirable Effects
  • Change to section 10 (date of (partial) revision of the text
Date of revision of text on the SPC:   09/2006
Legal Category:   POM
Black Triangle (CHM):   NO

Free-text change information supplied by the pharmaceutical company

Section 2 - updated to include the strains recommended by the WHO for 2006-2007.
 
Section 4.8 - updated to include angiodema.
 
Section 10 - updated date of revision of text.
Updated on 09/09/2005 and displayed until 18/09/2006
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Change to section 7 - Marketing Authorisation Holder
  • Change to section 10 (date of (partial) revision of the text
Updated on 29/09/2004 and displayed until 09/09/2005
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
  • Addition of Legal Category
  • Addition of new strength
Updated on 25/09/2003 and displayed until 29/09/2004
Reasons for adding or updating:
  • Change to section 2 - qualitative and quantitative composition
Updated on 25/09/2002 and displayed until 25/09/2003
Reasons for adding or updating:
  • Correction of spelling/typing errors
  • Addition of new strength
Updated on 22/08/2001 and displayed until 25/09/2002
Reasons for adding or updating:
  • New SPC for eMC ie an SPC for an existing product, but one that is new for the eMC

Active Ingredients/Generics

 
   influenza vaccine